Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yining Du

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Computational Intelligence and Neuroscience|January 3, 2022
Intelligent Error Correction of College English Spoken Grammar Based on the GA-MLP-NN AlgorithmYining Du
International Journal of Surgery (London, England)|November 4, 2025
Letter to the editor: loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studiesYining Du, Yuan Liu, Tianjie Zhu
International Journal of Surgery (London, England)|November 28, 2025
Letter to the editor: potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysisYining Du, Sen Gao, Nan Wang
Journal of Translational Medicine|June 26, 2026
Overcoming Paradigm Inertia: Publishing Incentives and Peer Review Bias as the True Rate-Limiting Steps in Reducing Animal ResearchYining Du, Yuan Fang, Shiwei Ni
Contemporary Clinical Trials|December 3, 2014
Simulation study for evaluating the performance of response-adaptive randomizationYining Du, Xuan Wang, J Jack Lee
Molecular Cancer|July 20, 2025
Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatmentYining Du, Jingyuan Zhao, Shuai Li, et al.
Journal of Biopharmaceutical Statistics|March 22, 2017
Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomizationYining Du, John D Cook, J Jack Lee
Viruses|April 27, 2026
Advances in Antiviral Drug Development Targeting Enteroviruses: From Viral Proteins to Host FactorsJiaying Lu, Congyi Li, Wenzhe Cui, et al.
Journal of Virology|January 8, 2025
Platelet factor 4-derived C15 peptide broadly inhibits enteroviruses by disrupting viral attachmentShuai Lv, Congyi Li, Zhichao Pei, et al.
Oncotargets and Therapy|May 12, 2018
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumorsTodd M Bauer, Manish R Patel, Andres Forero-Torres, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Computational Intelligence and Neuroscience|January 3, 2022
Intelligent Error Correction of College English Spoken Grammar Based on the GA-MLP-NN AlgorithmYining Du
International Journal of Surgery (London, England)|November 4, 2025
Letter to the editor: loss of RPN1 promotes antitumor immunity via PD-L1 checkpoint blockade in triple-negative breast cancer - experimental studiesYining Du, Yuan Liu, Tianjie Zhu
International Journal of Surgery (London, England)|November 28, 2025
Letter to the editor: potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysisYining Du, Sen Gao, Nan Wang
Journal of Translational Medicine|June 26, 2026
Overcoming Paradigm Inertia: Publishing Incentives and Peer Review Bias as the True Rate-Limiting Steps in Reducing Animal ResearchYining Du, Yuan Fang, Shiwei Ni
Contemporary Clinical Trials|December 3, 2014
Simulation study for evaluating the performance of response-adaptive randomizationYining Du, Xuan Wang, J Jack Lee
Molecular Cancer|July 20, 2025
Application of photodynamic activation of prodrugs combined with phototherapy in tumor treatmentYining Du, Jingyuan Zhao, Shuai Li, et al.
Journal of Biopharmaceutical Statistics|March 22, 2017
Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomizationYining Du, John D Cook, J Jack Lee
Viruses|April 27, 2026
Advances in Antiviral Drug Development Targeting Enteroviruses: From Viral Proteins to Host FactorsJiaying Lu, Congyi Li, Wenzhe Cui, et al.
Journal of Virology|January 8, 2025
Platelet factor 4-derived C15 peptide broadly inhibits enteroviruses by disrupting viral attachmentShuai Lv, Congyi Li, Zhichao Pei, et al.
Oncotargets and Therapy|May 12, 2018
A Phase Ib study of ruxolitinib + gemcitabine ± nab-paclitaxel in patients with advanced solid tumorsTodd M Bauer, Manish R Patel, Andres Forero-Torres, et al.
Pageof 2